Page 1 of 212

Camera-phone uses blood, saliva samples to diagnose disease Researchers at the University of California, Berkeley, have developed a prototype camera-phone mounted with a microscope that may magnify and photograph bloodstream or saliva samples for diagnosing illnesses, the Canadian Press/ reports . On Wednesday in the journal PLoS One A report on the device was published. The prototype, known as CellScope, would enable disease screening and diagnosis in the field where specific medical microscopy laboratories aren’t obtainable, including in underdeveloped countries, according to the news service . Using samples of contaminated bloodstream and sputum, the researchers were able to utilize the camera phone to fully capture bright field pictures of Plasmodium falciparum, the parasite that triggers malaria in humans, and sickle-shaped red blood cells, regarding to a UC Berkeley press release. Continue reading

Related StoriesApplying a high restaurant model to health care communications: an interview with Brandi Robinson, SanofiAdvances in nanofilter technology may lead to surgically implantable, artificial kidneyGenetic carrier screening: an interview with Don Hardison, CEO of Good Start GeneticsThe investigators discovered that 16 percent of the patients on dialysis had limited wellness literacy. There are more than 350,000 patients in the United States on dialysis, which means this represents a significant amount of people who could benefit from being better in a position to understand and manage their kidney wellness. Continue reading

Patients will apply the ointment twice daily for 12 weeks. Email address details are anticipated in the next half of 2011. Provided its size, the trial is not made to demonstrate statistical differentiation of AN2728 from vehicle, but to inform the design and size of the two planned pivotal Phase 3 trials for AN2728. Anacor also announced today the outcomes of its Phase 1 absorption trial for AN2728 which evaluated the topical pharmacokinetics, systemic safety, and local tolerability in 16 healthful volunteers. In this double-blind trial, 2 percent AN2728 ointment or vehicle ointment was used twice daily for seven days to 10 percent body surface area in one cohort and 35 percent BSA in another. Zero serious or serious adverse events were observed no meaningful laboratory or ECG abnormalities were found clinically. Continue reading

Clever ants may hold the secret to antibiotic resistance New research has revealed that ants that tend and harvest gardens of fungus keep on their bodies a top secret weapon, an antibiotic-producing bacteria, which works against the parasites that invade their crops. The international team of scientists found that the ants accommodate the bacterias in specifically adapted cavities on their bodies. It seems the bacteria thrive on glandular secretions and the discovery shows that the ants, bacteria, fungus and parasites have already been very likely evolving collectively for tens of an incredible number of years and also have what the experts say is a classic symbiotic relationship silagra-vs-viagra.html . Continue reading

Even when public research institutions are involved, the goal continues to be the same – – to create a pipeline of crop and seed technology that are proprietary, designed and patented to make corporations rich at the trouble of agricultural sovereignty. Most of Africa appears to recognize this, despite all of the Western propaganda, the biotech kingpins are still pushing hard to gain control over this profitable market. ‘Through IP mechanisms, public research institutions have become indistinguishable in their behaviour from corporations effectively,’ added Robinson. Continue reading

Boehringer Ingelheim announces option of PRADAXA in U.S. Pharmacies Boehringer Ingelheim Pharmaceuticals, Inc non-steroidal fertility med .S. Food and Medication Administration accepted PRADAXA on October 19, 2010 to lessen the chance of stroke and systemic embolism in sufferers with non-valvular atrial fibrillation. We’ve currently received an overwhelmingly positive response from the atrial fibrillation community and we’re pleased that innovative brand-new treatment will be designed for patients with the problem who are at elevated risk for stroke. The wholesale acquisition cost for both dosages of PRADAXA will end up being $6.75 a full day time for two capsules. Related StoriesResearchers associate neuroimaging data with reading deficits in sufferers with left-sided strokeStudy displays post-stroke lack of speech could be recoveredMore study required before recommending antidepressants, Alzheimer's disease medications for stroke recovery: StudyAt Boehringer Ingelheim, the fitness of our individuals is our first concern and we function diligently to make sure our medications are accessible and affordable for all individuals. Continue reading

The amount of time a molecule continues to be in its excited condition before emitting a photon–the fluorescence lifetime–provides unique information about the fluorescently-labeled molecule’s environment and its chemical structure. For example, a specific molecule might relax to its lowest-energy state quickly or slowly based on whether it is exposed to a solvent. We previously showed that our fluorescently-labeled membrane probe has a longer lifetime within a cholesterol-rich lipid domain, said Sheets. Here we display that adjustments in this lifetime follow the changes that occur through the first measures in the allergic response procedure. Continue reading

PRESS RELEASE -Significantly advances Cardinal Health's supplying of interventional cardiology and endovascular solutions for integrated wellness systems and their sufferers -Creates immediate global level and scope -Fiscal 2017, first full post-close year, accretion is expected to be greater than$0.20in non-GAAP diluted earnings per share from continuing functions; accretive thereafter DUBLIN increasingly, Ohio,March 2, 2015/PRNewswire/ – – Cardinal Health today announced programs to obtain Johnson & Johnson's Cordis business, a leading global manufacturer of cardiology and endovascular gadgets, for$1 how much does cialis cost .944 billionin cash, or approximately$1.594 billion, net of the present value of tax benefits. Continue reading

Moreover, IONICON provides an optimized inlet program for breath analysis with PTR-MS. Security of patients has become an increasing focus, and even products for non-invasive breath analysis have to comply with international rules. The IONICON BET-med system has been certified for clinical use, which allows real-time breath evaluation of individuals with IONICON PTR-TOFMS instruments .. Breath test for liver disease detection moves closer Researchers at the University of Birmingham have got published outcomes that suggest a non-invasive breath check for liver disease using an IONICON PTR-MS. Elevated levels of limonene in patients have been found to end up being indicative of a diseased liver. Continue reading

However, the clot-busting medication can only end up being administered within four. 5 hours of the onset of a stroke; when provided beyond that home window of time, the medication could cause bleeding in the mind. Based on the American Stroke Association, stroke may be the third leading reason behind death in the usa behind illnesses of the center and cancer. 795 Approximately, 000 Americans suffer a fresh or recurrent stroke each full year. Related StoriesAdvances entirely mount human brain imaging: an interview with Patrick Myles, President, Huron Digital PathologyInner ear harm mind warnings from nerve cellsScreening for asymptomatic atrial fibrillation could decrease threat of stroke, premature loss of life As much as a quarter of most stroke patients can’t be provided tPA because they awaken with stroke symptoms or cannot inform their doctor when their stroke started, said business lead researcher Catherine Oppenheim, M.D., Ph.D., professor of radiology at Universit – Paris Descartes in France. Continue reading

Page 1 of 212